Table 3.
Correlation coefficients of Spearman analysis between MNSI, metabolic syndrome components, and body composition data
| Variable | MNSI-Q | MNSI-PE | ||
|---|---|---|---|---|
|
|
|
|||
| rho | P | rho | P | |
| HbA1c (%) | 0.045 | 0.720 | 0.261 | 0.035 |
|
| ||||
| Diabetes duration (yr) | 0.083 | 0.516 | 0.087 | 0.493 |
|
| ||||
| Triglyceride (mg/dL) | 0.069 | 0.585 | 0.264 | 0.034 |
|
| ||||
| HDL cholesterol (mg/dL) | −0.067 | 0.595 | −0.208 | 0.097 |
|
| ||||
| SBP (mmHg) | −0.063 | 0.623 | 0.300 | 0.017 |
|
| ||||
| DBP (mmHg) | −0.177 | 0.164 | 0.253 | 0.045 |
|
| ||||
| HOMA-IR | −0.005 | 0.972 | 0.310 | 0.017 |
|
| ||||
| WC (cm) | 0.085 | 0.505 | 0.364 | 0.003 |
|
| ||||
| BMI (kg/m2) | −0.159 | 0.207 | 0.348 | 0.005 |
|
| ||||
| Fat mass (kg) | −0.032 | 0.799 | 0.357 | 0.004 |
|
| ||||
| Fat percent (%) | −0.021 | 0.870 | 0.332 | 0.007 |
|
| ||||
| Lean body mass (kg) | −0.165 | 0.190 | −0.067 | 0.597 |
|
| ||||
| Visceral fat area (cm2) | −0.006 | 0.190 | 0.330 | 0.007 |
MNSI, Michigan Neuropathy Screening Instrument; MNSI-Q, MNSI-questionnaire; MNSI-PE, MNSI-physical examination; HbA1c, glycosylated hemoglobin; HDL, high-density lipoprotein; SBP, systolic blood pressure; DBP, diastolic blood pressure; HOMA-IR, homeostatic model assessment for insulin resistance; WC, waist circumference; BMI, body mass index.